Found: 25
Select item for more details and to access through your institution.
Cytoreductive treatment patterns among US veterans with polycythemia vera.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0107-8
- By:
- Publication type:
- Article
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 11, p. 2555, doi. 10.1007/s00277-020-04055-w
- By:
- Publication type:
- Article
Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Recruitment strategies and geographic representativeness for patient survey studies in rare diseases: Experience from the living with myeloproliferative neoplasms patient survey.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243562
- By:
- Publication type:
- Article
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e1, doi. 10.1016/j.clml.2022.02.001
- By:
- Publication type:
- Article
Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e915, doi. 10.1016/j.clml.2021.06.023
- By:
- Publication type:
- Article
MPN-133: Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the REVEAL Prospective, Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S355, doi. 10.1016/S2152-2650(21)01820-6
- By:
- Publication type:
- Article
Poster: MPN-133: Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the REVEAL Prospective, Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S233, doi. 10.1016/S2152-2650(21)01467-1
- By:
- Publication type:
- Article
Oral Abstract: MPN-133: Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the REVEAL Prospective, Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01272-6
- By:
- Publication type:
- Article
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Essential Thrombocythemia Enrolled in the MOST Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 461, doi. 10.1016/j.clml.2021.02.011
- By:
- Publication type:
- Article
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Work Productivity Impairment and Symptom Burden among Patients with Myeloproliferative Neoplasms (MPNs): Findings from the Living with MPN Patient Survey.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S355, doi. 10.1016/j.clml.2017.07.184
- By:
- Publication type:
- Article
Are Patients with High-Risk Polycythemia Vera (PV) Receiving Cytoreductive Medications? A Retrospective Analysis of Real-World Data.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S356, doi. 10.1016/j.clml.2017.07.185
- By:
- Publication type:
- Article
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 1, p. 26, doi. 10.1159/000526599
- By:
- Publication type:
- Article
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 4, p. 448, doi. 10.1159/000520440
- By:
- Publication type:
- Article